Advanced Biomed Inc. 8-K

What Happened
Advanced Biomed Inc. (ADVB) filed a Form 8-K reporting a 1-for-20 reverse stock split of its common stock. The company filed a Certificate of Amendment with the Nevada Secretary of State on February 3, 2026, and the Common Stock began trading on a post-split basis on The Nasdaq Capital Market at the open on February 20, 2026. The company also issued a press release about the reverse split on February 18, 2026.

Key Details

• Reverse split ratio: 1-for-20 — every 20 pre-split shares automatically converted into 1 post-split share.
• Effective date/trading: Post-split trading began at the open of Nasdaq on February 20, 2026.
• Corporate details: Par value remained $0.001 per share; number of authorized shares was unchanged.
• Fractional shares: No fractional shares issued — record holders and street-name accounts were rounded up to the next whole share at the shareholder or participant level (no cash paid in lieu).
• Other identifiers: Post-split trading symbol remains "ADVB"; new CUSIP for the common stock is 00752P203.
• Filing references: Certificate of Amendment filed as Exhibit 3.1; press release dated Feb 18, 2026 filed as Exhibit 99.1. The company noted a material modification to holders’ rights to the extent required in connection with the reverse split.

Why It Matters
A reverse stock split reduces the number of outstanding shares and increases the per-share price proportionally, which can affect per-share metrics (e.g., reported EPS, price per share) and how investors view liquidity and trade sizes. There was no change to the company’s authorized share count or par value, and fractional-share holders were rounded up rather than paid cash. Investors should confirm updated share balances and the new CUSIP with their broker or account statement and note that ADVB continues to trade on Nasdaq under the same ticker.